DR. CHRISTOPHER RAY ENGLAND M.D.
Prescription History 1104073170
Otolaryngology - Plastic Surgery within the Head & Neck in Silverdale, WA

NPI Status: Active since August 21, 2008

Contact Information

2200 NW MYHRE RD
SILVERDALE, WA
ZIP 98383
Phone: (360) 830-1100
Fax: (360) 830-1385

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. CHRISTOPHER RAY ENGLAND M.D., an active Plastic Surgery within the Head & Neck specialist practicing in Silverdale, WA. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 207 documented patient claims. Among these therapy options, the most frequently utilized medication is Ipratropium Bromide, which accounts for 84 claims alone.

Medication Index


Azelastine Hcl

Generic Formulation: Azelastine HclSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 47
30-Day Fills 66.5
Days Supply 1,972
WA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills37.7
Peer Average Days Supply1,084
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 74.1% higher than the standard regional baseline profile for WA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,487.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.65

State Avg Cost Per Claim

$38.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms.

Epinephrine

Generic Formulation: EpinephrineSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 14
30-Day Fills 18.0
Days Supply 367
WA State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills18.3
Peer Average Days Supply392
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,957.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$282.68

State Avg Cost Per Claim

$319.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.

Ipratropium Bromide

Generic Formulation: Ipratropium BromideSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 84
30-Day Fills 97.2
Days Supply 1,629
WA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills38.1
Peer Average Days Supply1,022
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 211.1% higher than the standard regional baseline profile for WA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,159.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$37.62

State Avg Cost Per Claim

$53.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.

Therapeutic Applications

Ipratropium is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. For preventing symptoms of lung disease, this medication must be used regularly to be effective. Use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) for wheezing or sudden shortness of breath unless otherwise directed by your doctor. Ipratropium does not work as fast as your quick-relief inhaler, but may sometimes be used to relieve symptoms of wheezing or sudden shortness of breath if so prescribed by your doctor.

Mupirocin

Generic Formulation: MupirocinSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 165
WA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.9
Peer Average Days Supply427
Conservative Utilization

This provider writes prescriptions for this formulation 45.8% less frequently than the standard regional baseline metric for practitioners inside WA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $141.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.89

State Avg Cost Per Claim

$12.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

Therapeutic Applications

Mupirocin is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria.

Ofloxacin

Generic Formulation: OfloxacinSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 120
WA State Average Benchmarks
Peer Average Claims60.0
Peer Average 30-Day Fills63.5
Peer Average Days Supply1,278
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 81.7% less volume than the regional standard for practitioners inside WA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $474.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.17

State Avg Cost Per Claim

$18.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.

Therapeutic Applications

This medication is used to treat eye infections. Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 23
30-Day Fills 23.0
Days Supply 86
WA State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills50.1
Peer Average Days Supply920
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.1% less volume than the regional standard for practitioners inside WA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $82.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.57

State Avg Cost Per Claim

$21.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Prednisolone Acetate

Generic Formulation: Prednisolone AcetateSpecialty: Otolaryngology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.7
Days Supply 223
WA State Average Benchmarks
Peer Average Claims95.0
Peer Average 30-Day Fills120.6
Peer Average Days Supply3,071
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.2% less volume than the regional standard for practitioners inside WA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $610.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$40.70

State Avg Cost Per Claim

$48.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. CHRISTOPHER RAY ENGLAND M.D. provides transparency into local medical care patterns within Silverdale, WA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Plastic Surgery within the Head & Neck** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.